Gastroenterology Doctors in Jonesboro, AR Accepting Medicare

4 Gastroenterology doctors found. Showing 1 - 4

Michael D. Hightower, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 311 Matthews Ave, Jonesboro, AR 72401 Phone: 870-935-4150    Fax: 870-934-5368

Jeffrey Stidman, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-4462    Fax: 870-910-7744

Barry Matt Garner, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1000 East Matthews Suite E, Jonesboro, AR 72401 Phone: 870-336-0472    Fax: 870-336-5320

Donovan Ritchie Stockdale, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1000 East Matthews Suite E, Jonesboro, AR 72401 Phone: 870-336-0472    Fax: 870-336-5320

News Archive

TSRI scientist and partners receive $7.2 million grant to create new RNA-based treatments for ALS

Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic's Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).

Nanomedicine's giant step into the fight against the COVID-19

A recent editorial in Nature Nanotechnology discusses the enormous feat of scientific innovation, with messenger RNA (mRNA)-based vaccines developed to deliver the gene sequence of specific SARS-CoV-2 viral proteins into host cells using nanotechnology platforms.

Health bill stall creates uncertainty for drug makers

"With the possible demise of health care legislation, getting back to business as usual may not be the best thing for the nation's drug makers," The New York Times reports. "After all, in return for the prospect of tens of millions of newly insured customers and a large degree of regulatory certainty, the pharmaceutical industry had agreed to pay a relatively small price: $8 billion a year in discounts and fees.

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Read more Medical News

› Verified 8 days ago